Taiwan FDA registration 61d3a4eb57c56c636d05780d2e2eb5fb

"Litta" Immunopathological Histochemistry Reagents and Kits (Non-Sterilized)

TW: "立塔" 免疫病理組織化學試劑與套組(未滅菌)

Taiwan·Risk Class 1·Zeta Corporation·Registered Jul 11, 2024 – Jul 11, 2029Active

Registration details

Analysis ID: 61d3a4eb57c56c636d05780d2e2eb5fb
Customs Code: DHA09402353704

Company information

Manufacturer: Zeta Corporation
Manufacturer Country: United States
Authorized Representative: BOND BIOTECH, INC.

Product details

Intended Use: It is limited to the first level of identification scope of the "Immunopathological Histochemical Reagents and Sets (B.1860)" for the classification and grading management measures of medical devices.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.1860 Immunopathological histochemistry reagents and kits
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Jul 11, 2024
Expiry Date: Jul 11, 2029

About this record

Access comprehensive regulatory information for "Litta" Immunopathological Histochemistry Reagents and Kits (Non-Sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 61d3a4eb57c56c636d05780d2e2eb5fb and manufactured by Zeta Corporation. The authorized representative in Taiwan is BOND BIOTECH, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.